PerkinElmer Inc. (PKI)
-NYSE 31.76 
0.06(0.19%) 4:02PM EDT
| Prev Close: | 31.82 |
|---|
| Open: | 31.43 |
|---|
| Bid: | 30.35 x 100 |
|---|
| Ask: | 34.95 x 200 |
|---|
| 1y Target Est: | 36.43 |
|---|
| Beta: | 1.05 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 31.34 - 31.86 |
|---|
| 52wk Range: | 23.73 - 35.86 |
|---|
| Volume: | 1,127,194 |
|---|
| Avg Vol (3m): | 1,213,280 |
|---|
| Market Cap: | 3.56B |
|---|
| P/E (ttm): | 45.50 |
|---|
| EPS (ttm): | 0.70 |
|---|
| Div & Yield: | 0.28 (0.90%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- PKI Downgraded to UnderperformZacks(Mon, May 20)
- Illumina to partner for automation of sample preparation kitstheflyonthewall.com(Wed, May 15)
- Top Health Insurance Plans Expanded Coverage of the Verifi® Non-Invasive Prenatal Test to Detect Down Syndrome & Other Chromosomal AbnormalitiesBusiness Wire(Tue, May 14)
- PerkinElmer to Present at UBS Global Healthcare ConferenceBusiness Wire(Mon, May 13)
- PERKINELMER INC FinancialsEDGAR Online Financials(Sat, May 11)
- PERKINELMER INC Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Fri, May 10)
- Detecting Investment Potential In Medical Diagnostics Companiesat Seeking Alpha(Tue, May 7)
- PERKINELMER INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 6)
- Why Royalty And Milestone Partnership Dynamics Imply Trovagene Could Tripleat Seeking Alpha(Fri, May 3)
- Seven shorts for a possible May pullbackat MarketWatch(Thu, May 2)
- [video] Mad Money Uncovered: PerkinElmerat TheStreet(Wed, May 1)
- Jim Cramer: Buy Berkshire Hathaway, Kroger, PerkinElmer, But Sell This Stockat Wall St. Cheat Sheet(Wed, May 1)
- Cramer's 'Mad Money' Recap: The Unsinkable Stock Marketat TheStreet(Tue, Apr 30)
- [video] Could Breakups Unlock Hidden Value?at CNBC(Tue, Apr 30)
- Will The Latest PerkinElmer Agreement Help TrovaGene Tap Into A $22 Billion Market?at Seeking Alpha(Tue, Apr 30)
Key Statistics
| Forward P/E (1 yr): | 13.34 |
|---|
| P/S (ttm): | 1.69 |
|---|
| Ex-Dividend Date: | 17-Apr-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 2.04 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.48 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | 1.47 |
|---|
Business Summary
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide.
View More